Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better

被引：0
|
作者：
Mannucci, Pier Mannuccio [1 ]
机构：
[1] Mangiagalli & Regina Elena Fdn, IRCCS Maggiore Hosp, Sci Direct, Milan, Italy
来源：
BLOOD TRANSFUSION | 2010年 / 8卷 / 04期
关键词：
VON-WILLEBRAND-FACTOR; PREVIOUSLY UNTREATED PATIENTS; INHIBITOR DEVELOPMENT; RISK-FACTORS; IN-VITRO; PRODUCTS; EPIDEMIOLOGY; ANTIBODIES; RELEVANCE; PROTECTS;
D O I：
10.2450/2010.0072.10
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：288 / 291
页数：4
相关论文
共 50 条
  • [11] Why plasma-derived factor VIII?
    Aledort, Louis
    Carpenter, Shannon L.
    Cuker, Adam
    Kulkarni, Roshni
    Recht, Michael
    Young, Guy
    Leissinger, Cindy
    HAEMOPHILIA, 2019, 25 (03) : E183 - E185
  • [12] Lower inhibitor risk of plasma-derived factor VIII concentrates versus recombinant factor VIII concentrates in patients with severe haemophilia A : result from SIPPET study and comments
    Biron-Andreani, Christine
    Diaz, Isabelle
    Navarro, Robert
    Schved, Jean-Francois
    HEMATOLOGIE, 2019, 25 (02): : 93 - 99
  • [13] Plasma-derived versus recombinant factor concentrates in PUPs: a never ending debate?
    Berntorp, Erik
    HAMOSTASEOLOGIE, 2017, 37 (01): : 53 - 57
  • [14] Biological considerations of plasma-derived and recombinant factor VIII immunogenicity
    Lai, Jesse
    Hough, Christine
    Tarrant, Julie
    Lillicrap, David
    BLOOD, 2017, 129 (24) : 3147 - 3154
  • [15] The future of plasma-derived clotting factor concentrates
    Hoots, WK
    HAEMOPHILIA, 2001, 7 : 4 - 9
  • [16] The choice of plasma-derived clotting factor concentrates
    Mannucci, PM
    BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (02): : 273 - 290
  • [17] PHARMACOVIGILANCE FOR PLASMA-DERIVED CLOTTING FACTOR CONCENTRATES
    TAGARIELLO, G
    CAVALLIN, F
    DAVOLI, PG
    GAJO, GB
    DEBIASI, E
    TRALDI, A
    LANCET, 1993, 342 (8885): : 1489 - 1489
  • [18] Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors
    Matino, Davide
    Makris, Michael
    Dwan, Kerry
    D'Amico, Roberto
    Iorio, Alfonso
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (12):
  • [19] INHIBITOR QUESTIONS - PLASMA-DERIVED FACTOR-VIII AND RECOMBINANT FACTOR-VIII
    BRAY, G
    ANNALS OF HEMATOLOGY, 1994, 68 : S29 - S34
  • [20] Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII
    Qu, Jingyao
    Ma, Cheng
    Xu, Xiao-Qian
    Xiao, Min
    Zhang, Junping
    Li, Dong
    Liu, Ding
    Konkle, Barbara A.
    Miao, Carol H.
    Li, Lei
    Xiao, Weidong
    PLOS ONE, 2020, 15 (05):
12345